Boehringer Ingelheim files suit to block drug price negotiations. Is the fight ultimately headed for the Supreme Court?

Boehringer Ingelheim is the latest pharmaceutical company to sue the federal government over the Inflation Reduction Act in a fight some drug pricing experts say will likely make it to the Supreme Court.

The lawsuits seek to block an IRA program that will allow Medicare to negotiate drug prices, with…
Click here to view original post